1. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-6 myelodysplastic syndromes (MDS)

   • Yasushi Miyazaki

   Guideline 14 February 2020 Pages: 481 - 493

   

2. Introduction by the Guest Editor: Recent advances in biology and treatment of multiple myeloma

   • Hirokazu Tanaka

   Progress in Hematology 27 January 2020 Pages: 494 - 495

3. Molecular basis of clonal evolution in multiple myeloma

   • Yusuke Furukawa
   • Jiro Kikuchi

   Progress in Hematology 06 February 2020 Pages: 496 - 511

   

4. Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost

   • Kenshi Suzuki

   Progress in Hematology 03 March 2020 Pages: 512 - 518

   

5. Clinical value of measurable residual disease testing for multiple myeloma and implementation in Japan

   • Hiroyuki Takamatsu

   Progress in Hematology 07 February 2020 Pages: 519 - 529

   

6. Chimeric antigen receptor T-cell therapy for multiple myeloma

   • Naoki Hosen

   Progress in Hematology 25 January 2020 Pages: 530 - 534

   

7. Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience

   • Maryam Rassoulzadegan
   • Fereydoun Ala
   • Akbar Dorgalaleh

   Original Article 14 January 2020 Pages: 535 - 543

   

8. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission

   • Yoshiyuki Ogawa
   • Kunio Yanagisawa
   • Hiroshi Handa

   Original Article 14 January 2020 Pages: 544 - 549

   

9. Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid

   • Masahisa Arahata
   • Hiroyuki Takamatsu
   • Hidesaku Asakura

   Original Article 03 January 2020 Pages: 550 - 558

   

10. Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma

    • Da Jung Kim
    • Taeyun Kim
    • Ho Sup Lee

    Original Article 06 January 2020 Pages: 559 - 566

    

11. Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study

    • Takanori Fukuta
    • Noriko Nishimura
    • Yasuhito Terui

    Original Article 14 January 2020 Pages: 567 - 573

    

12. Favourable survival in “Discordant” acute gastrointestinal graft versus host disease (GI-GVHD) is explained by mild clinical course and treatment-responsive disease

    • Ashleigh P. Scott
    • Caitlin Thirunavukarasu
    • Siok-Keen Tey

    Original Article 07 January 2020 Pages: 574 - 578

13. Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review

    • Yoko Edahiro
    • Hajime Yasuda
    • Norio Komatsu

    Case Report 09 December 2019 Pages: 579 - 584

    

14. Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction

    • Takeshi Hara
    • Ryohei Suzuki
    • Hisashi Tsurumi

    Case Report 17 December 2019 Pages: 585 - 590

    

15. Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells

    • Behnam Sadeghi
    • Bo Ersmark
    • Olle Ringdén

    Case Report 18 December 2019 Pages: 591 - 594